Germany-Magdeburg: Pharmaceutical Products./ Drugs With The Active Substance Pyridostigmine (Atc: N07aa02)./ The Subject Of This Publication Is The Conclusion Of Non-Exclusive Discount Agreements According To Section 130a Paragraph 8 Sgb V For Finished Medicinal Products With The Active Ingredient Pyridostigmine (Atc: N07aa02) As Part Of A So-Called "Open-House Model". With The Specification Of Uniform Contract Conditions And A Uniform Access Procedure, All Suitable And Interested Pharmaceutical Companies Or Associations Of Pharmaceutical Companies Are Offered The Opportunity To Conclude Or Join A Discount Agreement In Accordance With Section 130 A (8) Sgb V For The Active Ingredients Mentioned In Section B. Interested Pharmaceutical Companies Can Request The Participation Documents And The Respective Contract From The Contact Address Given Under I.1). A Prerequisite For The Conclusion Of A Contract Is That The Interested Pharmaceutical Company Submits The Requested Participation Documents, Fully Completed And Signed.